Error loading player: No playable sources found
93550
Session I: Nuts and Bolts of Bioassays
Date
April 16, 2024
This product is not available for individual purchase, but it is available as part of the following products:
Session Speakers:
Lessons Learned for Potency Assays for Bispecific mAbs for Accelerated Programs
Marianne Hayes, Johnson & Johnson
Potency Assay Automation and How We Have Enhanced Cell Use and Production
Sheri Mahan-Hunter, Pfizer, Inc.
Potency Assurance for Cellular and Gene Therapy Products
Andrew P. Byrnes, CBER, FDA
In Vitro Functional Potency Assay Development and Qualification for a Late Stage AAV Based Gene Therapy Product
Debashree Basu, Ultragenyx Pharmaceutical Inc.
General
Tracks
Related Products
Lunch and Learn: Vendor Showcase
Lunch will be available in Ballroom A-C. Grab lunch and head back to Ballroom D-G for the Vendor Showcase…
CASSS Welcome and Introductory Comments and Keynote Presentation - Gaines and Losses Regarding the Harmonization of Specifications during the COVID-19 Pandemic: Science Versus the Fear Factor
Welcome to Bioassays 2024, thank you for joining us!
Session IV: Process Improvements/Innovation in Bioassays
QUANTIFYING ENDOGENOUS PROTEIN CONTENT TO MEASURE AND CONTROL POTENCY OF ANTIBODY-PROTAC CONJUGATES
Session III: Structure Function
MEANINGFUL BIOASSAYS TO ELUCIDATE STRUCTURE-FUNCTION AND DEMONSTRATE CONTROL
